GLG News by Neurologists (US)

FDA is evaluating Frova for  a new indicationThis could lead to more prescriptions for all triptansThis could improve Frova's market share

The article discusses the problem of pain medication abuse and briefly mentions several treatments under research.

This article raises an important issue which is not widely known by the general public or even among physicians.

This article describes an interesting study which may show that commonly prescribed medications (statins) have an added benefit.

Article describes a new promising TB vaccine.

Biogen Idec and Genentech have announced today that two patients with Lupus treated with Rituxan have died of Progressive Multifocal Leukoencephalopathy (PML). This is the same disease that affected 2 patients with Multiple Sclerosis and one with Crohn's disease who had received the Biogen Idec and...

Newer antipsychotics have been relied on for behavioral management in dementia, given presumed beneficial side effect profile.Study refutes this clinical idea.

Emerging pharmaceutical technology.Prescribing unique treatment specific for each patient.Possibly removing trial and error prescribing with more analytical approach.

NC stat uses non needle surface EMG for the simple diagnosis of common disorders such as CTS. Unfortunatley, SEMG is not reliable. Its utility was questioned as far back as 2000 and the problems reaffirmed in a technology assessment at the AAN in 2003.

Revisiting endogenous opioids for pain control is rehasing old ground, which has been disappointing.